Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 16/20 | 0.61 |
| ▸ | RAB9A | P51151 | 16/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.61 |
| ▸ | HPGD | P15428 | 7/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.55 |
| ▸ | RELA | Q04206 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1926464 | 0.91 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14465414 | 0.90 | NPC1 (0.53) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14465492 | 0.89 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14466533 | 0.89 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14465408 | 0.89 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14466552 | 0.89 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14465411 | 0.89 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14465525 | 0.89 | NPC1 (0.65) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14489965 | 0.89 | RAB9A (0.52) | NPC1RAB9ASMN1; SMN2HPGDKMT2A | |
| SCHEMBL14465398 | 0.89 | RAB9A (0.52) | NPC1RAB9ASMN1; SMN2HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9048436-B2 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-02 | — | — | US | disclosed |
| US-9048436-B2 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-06-02 | — | — | US | disclosed |
| EP-1976838-B1 | OXADIAZOLE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE OXADIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-20140299822-A1 | Oxadiazole Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20140299822-A1 | Oxadiazole Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-10-09 | — | — | US | disclosed |
| US-20130200344-A1 | Oxadiazole Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-08-08 | — | — | US | disclosed |
| US-20130200344-A1 | Oxadiazole Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Oxadiazole Derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-08-08 | — | — | US | disclosed |
| US-8389735-B2 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8389735-B2 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| WO-2007074893-A1 | OXADIAZOLE DERIVATIVE, AND LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE OXADIAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-07-05 | — | — | WO | disclosed |
| US-20070149784-A1 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-06-28 | — | — | US | disclosed |
| US-20070149784-A1 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149784-A1 | Oxadiazole derivative, and light emitting element, light emitting device, and electronic device using the oxadiazole derivative | OXA1L, ADRA1D, CRY1 | NPC1 4535/4885RAB9A 3546/4885SMN1; SMN2 2738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.